These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 22020560)
1. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Song Y; Xu Y; Wang Z; Chen Y; Yue Z; Gao P; Xing C; Xu H Int J Cancer; 2012 Sep; 131(5):1042-51. PubMed ID: 22020560 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Song YX; Yue ZY; Wang ZN; Xu YY; Luo Y; Xu HM; Zhang X; Jiang L; Xing CZ; Zhang Y Mol Cancer; 2011 Jan; 10():1. PubMed ID: 21205300 [TBL] [Abstract][Full Text] [Related]
4. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer. Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872 [TBL] [Abstract][Full Text] [Related]
5. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Xiong B; Cheng Y; Ma L; Zhang C Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819 [TBL] [Abstract][Full Text] [Related]
6. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis. Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028 [TBL] [Abstract][Full Text] [Related]
7. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845 [TBL] [Abstract][Full Text] [Related]
9. C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer. Sun D; Wang C; Long S; Ma Y; Guo Y; Huang Z; Chen X; Zhang C; Chen J; Zhang J Br J Cancer; 2015 Apr; 112(9):1491-500. PubMed ID: 25867276 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1. Wang L; Jiang CF; Li DM; Ge X; Shi ZM; Li CY; Liu X; Yin Y; Zhen L; Liu LZ; Jiang BH Oncotarget; 2016 Jan; 7(3):2660-71. PubMed ID: 26673620 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer. Inoue A; Yamamoto H; Uemura M; Nishimura J; Hata T; Takemasa I; Ikenaga M; Ikeda M; Murata K; Mizushima T; Doki Y; Mori M Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1410-8. PubMed ID: 25472644 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients. Liao W; Gu C; Huang A; Yao J; Sun R Clin Transl Oncol; 2016 May; 18(5):449-56. PubMed ID: 26329295 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer. Qu L; Liang L; Su J; Yang Z Eur J Cancer Prev; 2013 Nov; 22(6):512-22. PubMed ID: 23765094 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR). Wu D; Huang HJ; He CN; Wang KY Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675 [TBL] [Abstract][Full Text] [Related]
17. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation. Vicinus B; Rubie C; Stegmaier N; Frick VO; Kölsch K; Kauffels A; Ghadjar P; Wagner M; Glanemann M Oncol Rep; 2013 Sep; 30(3):1285-92. PubMed ID: 23817679 [TBL] [Abstract][Full Text] [Related]
18. Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice. Jin G; Ramanathan V; Quante M; Baik GH; Yang X; Wang SS; Tu S; Gordon SA; Pritchard DM; Varro A; Shulkes A; Wang TC J Clin Invest; 2009 Sep; 119(9):2691-701. PubMed ID: 19652364 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer. Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase. Yu HG; Tong SL; Ding YM; Ding J; Fang XM; Zhang XF; Liu ZJ; Zhou YH; Liu QS; Luo HS; Yu JP Int J Cancer; 2006 Dec; 119(12):2724-32. PubMed ID: 16998832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]